2027, Food and Drug Administration, Healthcare and Safety

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2027

Food and Drug Administration

Healthcare

Safety

Delivery systems for biologics

European Pharmaceutical Review

MARCH 4, 2024

1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5

Food and Drug Administration

Food and Drug Administration Transportation FDA Medical

Moving towards oral delivery of biologics

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics.

Food and Drug Administration

Food and Drug Administration Manufacturing Safety Pharmaceutical

Pharma Rep Focus

Delivery systems for biologics

Moving towards oral delivery of biologics

Stay Connected